Search for a command to run...
Roche Holding AG
Drug Manufacturers - General
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jul 11, 2025 |  Ritchie John TorresD | Stock | Sell |
| $1,001 - $15,000 |
| $39.25 |
| $37.06 |
| -5.6% |
| -7.8% |
Apr 21, 2025 |  Bruce WestermanR | Stock | Sell | $1,001 - $15,000 | $37.61 | $38.18 | +1.5% | -11.9% |
Apr 9, 2025 |  Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $35.96 | $37.19 | +3.4% | +0.6% |
Mar 3, 2025 | Bruce WestermanR | Stock | Buy | $1,001 - $15,000 | $40.48 | $39.37 | -2.8% | +0.3% |
Sarepta: Safety And Efficacy Flaws Undermine Gains On Restructuring News
Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 | Advancements in Anti-VEGF Therapies Driving Progress in Treatments
Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information